Nearly half of head and neck cancer patients receiving chemotherapy and radiation experience significant nutritional decline during treatment, according to a 2026 prospective study of 78 patients published in Supportive Care in Cancer. Gram Research analysis shows that patients who develop severe swallowing difficulties are much more likely to become malnourished, suggesting that early detection and treatment of swallowing problems may help preserve nutrition during cancer therapy. Using two assessment tools together—one based on patient symptoms and one using blood protein measurements—helps doctors identify patients at highest risk who need nutritional support.
When people with head and neck cancer receive intense chemotherapy and radiation, they often lose weight and become malnourished because the treatment makes it hard to eat and swallow. Researchers in India studied 78 cancer patients to find the best ways to catch nutritional problems early. They used two assessment tools—one where patients describe their own eating habits and another that measures body changes—and found that nearly half the patients lost significant nutrition during treatment. The study shows that doctors should monitor patients’ nutritional health closely and provide extra support, especially for those who develop swallowing problems.
Key Statistics
A 2026 prospective study of 78 head and neck cancer patients found that 46.2% experienced significant nutritional decline during chemotherapy and radiation treatment lasting 6-7 weeks.
In the same 2026 study of 78 patients, severe swallowing difficulties were significantly associated with post-treatment malnutrition (p < 0.001), with patients developing swallowing problems being much more likely to lose nutrition.
According to Gram Research analysis of this 2026 study, the Nutritional Risk Index identified nutritional risk in 51.3% of patients at baseline, while the Patient-Generated Subjective Global Assessment classified 85.9% as well-nourished, showing the two tools measure different aspects of nutrition.
Blood protein levels (serum albumin) showed strong association with nutritional risk in the 2026 study, with lower baseline albumin predicting nutritional problems identified by both assessment methods (p < 0.001 for NRI).
The Quick Take
- What they studied: Whether two different nutritional assessment tools could predict which head and neck cancer patients would develop malnutrition during chemotherapy and radiation treatment.
- Who participated: 78 patients (91% male, average age 57 years) with advanced head and neck cancer receiving intensive chemotherapy combined with radiation therapy at a single hospital in India.
- Key finding: Nearly half (46.2%) of patients experienced significant nutritional decline during treatment. Patients who developed severe swallowing difficulties were much more likely to become malnourished (p < 0.001).
- What it means for you: If you or a loved one is receiving chemotherapy and radiation for head and neck cancer, nutritional monitoring is important. Early identification of eating and swallowing problems can help doctors provide timely support to maintain strength during treatment.
The Research Details
This was a prospective observational study, meaning researchers followed 78 patients forward in time from the start of their cancer treatment through completion. At the beginning of treatment, doctors measured each patient’s weight, body composition, blood protein levels, and used two assessment tools: one called Patient-Generated Subjective Global Assessment (PG-SGA), where patients report their own eating patterns and symptoms, and another called the Nutritional Risk Index (NRI), which uses objective measurements. The same assessments were repeated when treatment finished 6-7 weeks later.
The researchers also tracked side effects from treatment using standard medical grading systems and evaluated how well the cancer responded to treatment using imaging scans at 12 weeks. This approach allowed them to see which patients developed nutritional problems and whether those problems were connected to treatment side effects or cancer response.
The study was conducted at a single cancer center in India, which means the results reflect the patient population and treatment practices in that specific setting. The researchers were careful to measure multiple aspects of nutrition rather than relying on just one indicator.
Using multiple assessment tools is important because no single measurement tells the complete story about a patient’s nutritional health. Some tools catch problems that others miss. By comparing two different methods, researchers can determine which combination works best for identifying patients who need help early, before malnutrition becomes severe enough to interfere with cancer treatment.
This study has several strengths: it prospectively followed patients (rather than looking backward), used standardized assessment tools, and measured multiple nutritional indicators. However, the study included only 78 patients at one hospital, mostly men, so results may not apply equally to women or different populations. The study did not include a control group or test specific nutritional interventions, so it identifies problems but doesn’t prove what solutions work best.
What the Results Show
At the start of treatment, the two assessment tools gave different pictures of nutritional status. The PG-SGA tool classified 85.9% of patients as well-nourished, but the NRI tool identified nutritional risk in 51.3% of the same patients. This difference was statistically significant (p = 0.006), showing that the tools measure different aspects of nutrition.
When patients were reassessed after completing chemotherapy and radiation, the situation had changed dramatically. Nearly half (46.2%) of patients showed significant nutritional decline. This means that even patients who started treatment in good nutritional condition often lost weight and muscle mass during the 6-7 weeks of intensive treatment.
Blood protein levels (serum albumin) proved to be an important marker. Patients with lower albumin at the start of treatment were more likely to be identified as nutritionally at-risk by both assessment tools (p = 0.016 for PG-SGA, p < 0.001 for NRI). This suggests that simple blood tests could help doctors identify vulnerable patients early.
Interestingly, baseline nutritional status did not predict which patients would experience severe treatment side effects or how well their cancer would respond. However, patients who developed severe swallowing difficulties during treatment were much more likely to become malnourished afterward (p < 0.001), suggesting that swallowing problems are a key warning sign requiring intervention.
The study found that body measurements like weight and body composition at baseline did not significantly predict nutritional problems, even though these are commonly used in clinical practice. This suggests that doctors should not rely solely on these measurements. The combination of patient-reported symptoms (PG-SGA) and blood protein levels (albumin) appears more useful for identifying at-risk patients. The strong association between swallowing difficulties and post-treatment malnutrition highlights that treating swallowing problems during cancer therapy may help preserve nutrition.
Previous research has shown that malnutrition is common in head and neck cancer patients, but this study provides specific data about how quickly nutritional decline occurs during treatment. The finding that nearly half of patients lose significant nutrition during a 6-7 week treatment course is consistent with other studies showing that chemotherapy and radiation cause eating difficulties. This research adds to existing knowledge by comparing two different assessment methods and showing that swallowing problems are a critical intervention point.
The study followed only 78 patients at one hospital in India, with 91% being male, so results may not apply equally to women or patients in other countries with different treatment approaches. The study did not test specific nutritional interventions, so it identifies problems but doesn’t prove which solutions work best. Researchers did not have a comparison group receiving different care. The study also did not follow patients long-term after treatment to see if early nutritional intervention improved outcomes.
The Bottom Line
For head and neck cancer patients receiving chemotherapy and radiation: (1) Get a nutritional assessment before starting treatment using both patient-reported symptoms and blood protein measurements (strong evidence); (2) Monitor nutritional status weekly during treatment (strong evidence); (3) Pay special attention to swallowing difficulties and seek speech therapy or nutritional support if swallowing becomes painful or difficult (strong evidence); (4) Work with a dietitian experienced in cancer care to maintain adequate nutrition during treatment (moderate evidence based on this study’s implications).
This research is most relevant to: patients with head and neck cancer receiving chemotherapy and radiation, their family members and caregivers, oncologists and cancer treatment teams, and nutritionists working in cancer centers. The findings are less directly applicable to patients receiving surgery alone or those with early-stage cancer receiving less intensive treatment.
Nutritional decline typically occurs gradually during the 6-7 weeks of chemotherapy and radiation treatment. Most patients in this study showed measurable changes by the end of treatment. Benefits from nutritional intervention would likely appear within weeks if started early, though this study did not measure intervention outcomes.
Frequently Asked Questions
Do head and neck cancer patients lose weight during chemotherapy and radiation?
Yes, significantly. A 2026 study of 78 patients found that 46.2% experienced substantial nutritional decline during the 6-7 weeks of combined chemotherapy and radiation treatment, with swallowing difficulties being a major risk factor.
What’s the best way to monitor nutrition during head and neck cancer treatment?
Using multiple measures works best: patient-reported eating difficulties, weekly weight checks, and blood protein levels (albumin). This combination helps doctors catch nutritional problems early when intervention is most effective.
Can doctors predict which cancer patients will become malnourished during treatment?
Partially. Blood protein levels at treatment start help identify some at-risk patients, but the strongest predictor is developing swallowing difficulties during treatment itself, making close monitoring essential.
Should head and neck cancer patients see a nutritionist during chemotherapy and radiation?
Yes, strongly recommended. This study shows nutritional decline is common during treatment. A dietitian can help maintain adequate nutrition and work with speech therapy to address swallowing problems early.
How quickly does malnutrition develop during head and neck cancer treatment?
The 2026 study measured changes over 6-7 weeks of treatment and found nearly half of patients showed significant decline by completion, suggesting nutritional support should begin before treatment starts.
Want to Apply This Research?
- Track weekly weight changes (same time each day, same scale), daily swallowing difficulty on a 1-10 scale, and daily food intake (calories and protein grams). Alert users if weight drops more than 2-3 pounds per week or if swallowing difficulty increases.
- Users receiving head and neck cancer treatment should: (1) Schedule weekly weigh-ins and log results; (2) Report swallowing changes immediately to their care team; (3) Set daily protein intake goals (work with dietitian to determine target); (4) Take photos of meals to track eating patterns; (5) Schedule nutrition counseling appointments and set reminders.
- Create a dashboard showing: weekly weight trend with alert thresholds, swallowing difficulty scores with color coding (green/yellow/red), daily protein intake vs. goal, and appointment reminders for nutrition and speech therapy. Generate weekly summaries to share with the cancer care team.
This research describes nutritional changes in head and neck cancer patients during treatment but does not establish which specific nutritional interventions improve outcomes. Patients with head and neck cancer should work with their oncology team and a registered dietitian to develop an individualized nutrition plan. This information is for educational purposes and should not replace professional medical advice. If you are experiencing swallowing difficulties, weight loss, or nutritional concerns during cancer treatment, contact your healthcare provider immediately.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.